期刊文献+

绝经后骨质疏松症的T细胞亚群的变化及意义 被引量:7

Change and Significance of T Cell Subsets in Postmenopausal Women with Osteoporosis
下载PDF
导出
摘要 目的探讨绝经后骨质疏松症女性患者外周血的T细胞亚群的改变及意义.方法流式细胞仪检测68例绝经后骨质疏松症女性及60例无骨质疏松症绝经后女性外周血的T细胞亚群,绝经后骨质疏松症女性患者外周血的T细胞亚群的改变.结果绝经后骨质疏松症女性患者外周血的T抑制/毒性淋巴细胞(Ts)比率降低,Th/Ts比值升高,NK细胞、B淋巴细胞升高(P<0.05).结论外周血的T淋巴细胞亚群的变化可能促进了OP的发生发展.NK细胞、B淋巴细胞在体液免疫、免疫应答当中也出现相应的改变,进一步加重了绝经期妇女的免疫紊乱. Objective To investigate the change and significance of peripheral blood T cell subsets in postmenopausal women with osteoporosis. Methods Peripheral blood T cell subsets in postmenopausal women with osteoporosis (n =68) and postmenopausal women without osteoporosis (n =60) subjects were detected by flow cytometry. Results The ratio of peripheral blood T suppressor/cytotoxic lymphocytes (Ts) was decreased, while Th/Ts ratio, NK cells and B lymphocytes levels were increased in postmenopausal women with osteoporosis. Conclusion Changes in peripheral blood T lymphocyte subsets may promote the development of the osteoporosis. NK cells and B lymphocytes in humoral immune response are also changed, which can further exacerbate the immune disorder of menopausal women.
出处 《昆明医科大学学报》 CAS 2015年第4期34-36,共3页 Journal of Kunming Medical University
基金 云南省卫生厅卫生科技计划项目(2007C009Z 2012ws0031)
关键词 T细胞类别 CD4^+Th细胞 绝经 骨质疏松症 T cell subsets CD4^+Th Menopause osteoporosis
  • 相关文献

参考文献9

  • 1OKAMOTO K,TAKAYANAGI H. Regulation of bone by the adaptive immune system in arthritis [J]. Arthritis Res]'her, 2011,13(3 ):219.
  • 2ISLANDER U ,JOCHEMS C ,LAGERQUIST M K,et al. E- strogens in rheumatoid arthritis; the immune system and bone[ J ]. Mol Cell Endocrinol, 201 I, 335( I ): 14-29.
  • 3MARUOTYI N, GRANO M,COLUCCI S,et al. Osteoclas- togenesis and arthritis [J]. Clin Exp Med,2011,11 (3): 137- 145.
  • 4COMPSTON J. Guideline for the management of osteo- porosis:the present and the future [J]. Osteoporos Int, 2005,16( 16): 1 173-1 176.
  • 5VAN GEEL T A, NGUYEN N D, GEUSENS P P,et al. De- velopment of a simple prognostic nomogram for individual- ising 5-year and lO-year absolute risks of fracture: a popu- lation-based prospective study among postmenopausal women[J]. Ann Rheum Dis,2011,1(70):92-97.
  • 6HICKEY M,AMBEKAR M, HAMMOND I. Should the o- varies be removed or retained at the time of hysterectomy for benign disease [J]. Hum Reprod Update,2010,2 (16): 131-141.
  • 7DANKS L,TAKAYANAGI H. Immunology and bone EJ]. J Biochem,2013,154(1 ):29-39.
  • 8何勇,刘树琴,王长江,贾敬华,王佑民,章秋,潘天荣.IL-6、TNF-α在绝经后骨质疏松症发生中的作用[J].中国临床保健杂志,2007,10(1):41-43. 被引量:19
  • 9KOMANO Y, NANKI T, HAYASHIDA K, et al.ldentifica- tion of a human peripheral blood monocyte subset that dif- ferentiates into osteoclasts [ J ]. Arthritis Res Ther, 2006,8 (5):R152.

二级参考文献9

  • 1[1]Pfeilschifter J,Koditz R,pfohl M,et al.Changes in proinflam matory cytokine activity after menopause[J].Endocr Rev,2002,23(1):90-119.
  • 2[2]Bismar H,Die I,Ziegler R,et al.Increased cytokine secretion by human bone marrow ceils after menopause of discontinuation of estrogen replacement[J].J Clin Endocrinol Metab,1995,80:3351-3355.
  • 3[3]Girasole G,Giuliani N,Modena AB.et al.Oestrogens prevent the increase of human serum soluble interleukin-6 receptor induced by ovariecto my in vivo and de crease its release in human osteoblastic cells in vitro[J].Clin Endocrinol(Oxf),1999,51(6):801-807.
  • 4[5]Rachon D,Mysliwska J,Suchecka-Rachon K,et al.Effects of oestrogen deprivation on interleukci-6 production by peripheral blood mononuckear cells of postmenopausal women[J].J Endocrinol,2002,172(2):387-395.
  • 5[6]Rachon D.Role of tumor necrosis factor (TNF) and interleukin-6 (IL-6) in the pathogenesis of late complications of menopause.Effects of hormone replacement therapy on TNF and IL-6 expression[J].Pol merkuriusz Lek,2005,18(108):724-727.
  • 6[8]Scheidt NC,Bismar H,Leidig BG,et al.Serum in-terleakin-6 is a major predictor of bone loss in woman specific to the first decode postmenopause[J].J Clin Endocrinol Metab,2001,86(5):2032-2042.
  • 7[9]Poliv Balena R,Fattori E,Markatos A.Interleakin-6 deficient mice are protected from bone loss caused by estrogen depletion[J].EMBO J,1994,13(5):1189-1196.
  • 8周丕琪,沈霖,杜靖远,杨艳萍,谢晶,高兰,刘保平.绝经后骨质疏松症与血清IL-6,TNF-α浓度关系的临床研究[J].中国骨质疏松杂志,2001,7(1):1-3. 被引量:50
  • 9魏合伟,侯书丽,龚钰,黎同明,胡标伦,刘庆思.白细胞介素-6在绝经后骨质疏松症发病机制中作用的临床研究[J].广州中医药大学学报,2002,19(2):94-95. 被引量:12

共引文献18

同被引文献73

  • 1李世和.骨质疏松症的诊断与治疗[J].昆明医学院学报,2007,28(5):122-124. 被引量:4
  • 2COMPSTON J. Guidelines for the management of osteoporosis: the present and the future [J]. Osteoporos Int,2005,16(10):1173-1176.
  • 3COLE Z A,DENNISON E M,COOPER C. Osteoporosis epidemiology update [J]. Curr Rheumatol Rep,2008,10(2):92-96.
  • 4LISTON A,GRAY D H. Homeostatic control of regulatory T cell diversity [J]. Nat Rev Immunol,2014,14(3):154-165.
  • 5SAKAGUCHI S,REGULATORY T. Cells: key controllers of immunologic self-tolerance [J]. Cell,2000,101(5):455-458.
  • 6LI X,LIANG Y,LEBLANC M,et al. Function of a Foxp3 cis-element in protecting regulatory T cell identity [J]. Cell,2014,158(4):734-748.
  • 7SON H J,LEE J,LEE S Y, et al. Metformin attenuates experimental autoimmune arthritis through reciprocal regulation o?Thl7/Treg balance and osteoclastogenesis[J]. Mediators Inflamm,2014,2014N:973986.
  • 8PARK J S, KWOK S K,LIM M A,et al.STA-21,a promising STAT-3 inhibitor that reciprocally regulates Th 17 and Treg cells, inhibits osteoclastogenesis in mice and humans and alleviates autoimmune inflammation in an experimental model of rheumatoid arthritis [J]. Arthritis Rheumatol,2014,66(4):918-929.
  • 9ZAISS M M,FREY B,HESS A,et al. Regulatory T cells protect from local and systemic bone destruction in arthritis [J]. J Immunol,2010,184(12):7238-7246.
  • 10ZAISS M M,AXMANN R,ZWERINA J,et al. Treg cells suppress osteoclast formation: a new link between the immune system and bone [J]. Arthritis Rheum,2007,56(12):4104-4112.

引证文献7

二级引证文献73

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部